Chlorpromazine and the Untreated Chronic Schizophrenic: A Long-Term Trial
- 1 September 1967
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 113 (502) , 950-958
- https://doi.org/10.1192/bjp.113.502.950
Abstract
Although chlorpromazine was the first of the phenothiazine drugs to be used in psychiatry, and has since been the subject of an extensive literature, there is a surprising dearth of information about the nature of its effect in chronic schizophrenia. Some early reports indicated that it produced a beneficial change, but before this could be examined and documented the attention of most psychiatrists was diverted to newer and supposedly more potent analogues. The present trial was undertaken with three factors in mind, which had not been fully taken into account of in previous studies. These were:This publication has 6 references indexed in Scilit:
- The Clinical Effects on a Population of Chronic Schizophrenic Patients of Administrative Changes in HospitalThe British Journal of Psychiatry, 1967
- A Rating Scale of the Mental State: For Use in the Chronic Population of the Psychiatric HospitalThe British Journal of Psychiatry, 1967
- A critical review of some published experiments with chlorpromazine in schizophrenic, neurotic, and normal humansJournal of Chronic Diseases, 1960
- The influence of side-effects on the reporting of symptomsPsychopharmacology, 1959
- THE VALIDITY OF THE FORREST REAGENT TEST FOR THE DETECTION OF CHLORPROMAZINE OR OTHER PHENOTHIAZINES IN THE URINEAmerican Journal of Psychiatry, 1958
- A SIMPLE TEST FOR THE DETECTION OF CHLORPROMAZINE IN URINEAmerican Journal of Psychiatry, 1957